Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-16

Clinical Trial Update: Bioidentical 'Natural' Hormone Evaluation in Early Menopause [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bioidentical 'natural' hormone therapy for early menopause was terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bioidentical Hormone Therapy (bioidentical hormone therapy)

Snippet

Sponsor: Jeanne Drisko, MD, CNS, FACN | Conditions: Menopause | Phase 2 | Status: TERMINATED | Results posted: 2018-05-16